![](images/graphics/blank.gif)
Dyspnea evaluation
-
Most patients with unilateral diaphragm paralysis (UDP) have unexplained dyspnea, exercise limitations, and reduction in inspiratory muscle capacity. We aimed to evaluate the generation of pressure in each hemidiaphragm separately and its contribution to overall inspiratory strength.
9p
vimontana2711
05-04-2021
7
2
Download
-
Indacaterol is a novel, once-daily (od), inhaled, long-acting ß2-agonist bronchodilator for maintenance treatment of airflow limitation in patients with COPD. The aim of this study was to evaluate the efficacy of indacaterol on dyspnea, using available randomized placebo-controlled trials.
8p
vimontana2711
05-04-2021
12
2
Download
-
Two once-daily long-acting muscarinic antagonists (LAMAs) are currently available for the treatment of chronic obstructive pulmonary disease (COPD) – tiotropium and glycopyrronium. Previous studies have compared glycopyrronium with open-label tiotropium.
11p
vimontana2711
05-04-2021
8
1
Download
-
Dyspnea may be a presenting symptom in progressive systemic sclerosis (SSc). Respiratory drive (mouth occlusion pressure, MOP, at rest and during CO2 rebreathing, 7% CO2, 93% O2) is a major determinant of dyspnea and may relate to the magnitude of dyspnea.
6p
vimontana2711
05-04-2021
12
1
Download
-
To examine risk factors for asthma patients’ emergency room (ER) visits in a well organized asthma care setting. Methods: A random sample of 344 asthma patients from a Pulmonary Clinic of a University Hospital were followed through medical records from 1995 to 2006. All the ER visits due to dyspnea, respiratory infections, chest pain, and discomfort were evaluated.
9p
vimontana2711
05-04-2021
10
1
Download
-
This paper reviews evidence and quality of Systematic Reviews (SRs) on the effects of breathing control exercises (BCEs) and respiratory muscle training (RMT) on breathlessness/dyspnea and other symptoms, and quality of life (QOL) for individuals with chronic obstructive pulmonary disease (COPD).
15p
vimontana2711
05-04-2021
11
1
Download
-
This study evaluated the effects of aclidinium bromide, a long-acting muscarinic antagonist indicated for maintenance treatment of chronic obstructive pulmonary disease (COPD), on exercise endurance, dyspnea, lung hyperinflation, and physical activity.
12p
vimontana2711
05-04-2021
10
1
Download
-
Dyspnea, fatigue, and decline in sleep quality are symptoms of chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation programs have been shown to ameliorate dyspnea and fatigue. However, only a few studies have investigated the effects of pulmonary rehabilitation on the sleep quality of COPD patients.
7p
vimaine2711
26-03-2021
12
2
Download
-
Dyspnea is the subjective sensation of uncomfortable or difficult breathing. Most patients report dyspnea as "shortness of breath." Patients report dyspnea when their breathing is excessive for the activity that they are doing. The sensation of dyspnea is produced by stimulation of both central and peripheral receptors that monitor respiratory muscle activity, hypoxia, hypercapnia, acid-base status, airway irritation, and changes in the pressure volume characteristics of the lung (i.e., j receptors in lung fibrosis or emphysema).
555p
gian_anh
18-10-2012
60
6
Download
-
Although dyspnea is a common symptom, there has been only limited investigation of its prognostic significance among patients referred for cardiac evaluation. methods We studied 17,991 patients undergoing myocardial-perfusion single-photon-emission computed tomography during stress and at rest. Patients were divided into five categories on the basis of symptoms at presentation (none, nonanginal chest pain, atypical angina, typical angina, and dyspnea).
11p
muakhuya
07-07-2012
64
4
Download
CHỦ ĐỀ BẠN MUỐN TÌM
![](images/graphics/blank.gif)